Literature DB >> 5819419

Correlation of serum creatinine concentration and kanamycin half-life. Therapeutic implications.

R E Cutler, B M Orme.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5819419

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Scientific commentary. Drug absorption and disposition as monitors of safety and efficacy.

Authors:  B E Cabana; L W Dittert
Journal:  J Pharmacokinet Biopharm       Date:  1975-04

2.  Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.

Authors:  T G Christopher; A D Blair; A W Forrey; R E Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

Review 3.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

5.  Pharmacokinetics of gentamicin and kanamycin during hemodialysis.

Authors:  M Danish; R Schultz; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

Review 6.  The pharmacological role of the kidney.

Authors:  D C Brater
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

7.  Principles of drug therapy in patients with renal disease.

Authors:  W M Bennett
Journal:  West J Med       Date:  1975-11

Review 8.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans.

Authors:  K G Naber; S R Westenfelder; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

Review 10.  Nomograms for drug use in renal disease.

Authors:  P Chennavasin; D C Brater
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.